Athenex Competitors and Similar CompaniesClear all
Athenex's competitors and similar companies include Telix Pharmaceuticals, ASLAN Pharmaceuticals, Plus Therapeutics and AskGene Pharma.
 Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. |  Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. |  ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. |  Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  AskGene Pharma AskGene Pharma is a developer of prodrugs for oncology, ophthalmology, and autoimmune disease treatment. | |
Founding Date | Founding Date 2003 | Founding Date 2015 | Founding Date N/A | Founding Date 1996 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations SG HQ Collingwood, AU | Locations Austin, US HQ San Antonio, US | Locations Camarillo, US HQ | ||
Employees | Employees 575 | Employees 415 | Employees 35 | Employees 1721% increase | Employees 910% decrease |
Valuation ($) | Valuation ($) 2.3 m | Valuation ($) 4.6 b | Valuation ($) N/A | Valuation ($) 8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $102.8m (FY, 2022) | Revenue (est.) $803.8m (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $76.1m (FY, 2022) | Cost of goods $356m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $26.7m (FY, 2022) | Gross profit $449m (FY, 2025) | Gross profit $12m (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($104.4m) (FY, 2022) | Net income ($7.1m) (FY, 2025) | Net income ($44.2m) (FY, 2023) | Net income ($22.4m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 252.1m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 71.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Telix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
View companyASLAN Pharmaceuticals
HQ
SG
Employees
35
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
View companyPlus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
View companyAskGene Pharma
HQ
Camarillo, US
Employees
9↓ 10% decrease
AskGene Pharma is a developer of prodrugs for oncology, ophthalmology, and autoimmune disease treatment.
View company